Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fujie Lotion is a topical Traditional Chinese Medicine (TCM) preparation developed and manufactured by Conchen Pharmaceutical, a subsidiary of Consun Pharmaceutical Group. It is an approved therapy in China primarily indicated for the treatment of gynecological bacterial infections, including various forms of vaginitis (colpitis) and vulvovaginal pruritus. The formulation is composed of several herbal extracts, including *Sophora flavescens* (Ku Shen), *Phellodendron amurense* (Huang Bai), *Cnidium monnieri* (She Chuang Zi), *Kochia scoparia* (Di Fu Zi), and *Carthamus tinctorius* (Hong Hua), along with borneol. These components provide a synergistic therapeutic effect characterized by broad-spectrum antimicrobial, antifungal, and anti-inflammatory properties. The lotion is intended for external use as a wash to alleviate symptoms such as itching, abnormal discharge, and inflammation associated with vaginal and vulvar infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fujie Lotion.